State Ledger
Company profile

REPLIGEN CORP CIK 730272

Ticker
RGEN (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Waltham, MA 02453
Fiscal year end
2025 (FY)
Market Data
Close
$172.60
Change
-$1.44
Change %
-0.82%
Volume
71,195

RGEN · trading date Oct 12, 2026 · previous close $174.04 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
$48.89M
Total assets
$2.95B
Total liabilities
$843.57M
Stockholders' equity
$2.11B
Cash & equivalents
$566.02M
Operating income
$55.17M
Operating cash flow
$117.42M
Capital expenditures
$23.52M

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
$93.90M
Free cash flow margin
—
Liabilities / assets
28.6%
Equity / assets
71.4%
CapEx / revenue
—
Operating cash flow / net income
2.40×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — $48.89M $2.95B $843.57M $2.11B
2024 — -$25.51M $2.83B $856.95M $1.97B
2023 — $35.60M $2.83B $866.34M $1.96B
2022 — $185.96M $2.53B $620.90M $1.91B
2021 — $128.29M $2.36B $608.29M $1.75B
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-15
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Waltham, MA 02453
41 SEYON STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies